Alcohol Abuse Clinical Trial
— FoBeMAOfficial title:
Internet-Based Relapse Prevention With Therapist Support vs Face to Face Therapy at an Employee Assistance Program: A Randomized Controlled Non-inferiority Trial
Objectives: This study will evaluate the efficacy of internet-based relapse prevention with
therapist support, as compared to face-to-face therapy at an employee assistance program.
The design is a two-armed randomized controlled design, and outcomes are measured in terms
of changes in problematic alcohol use, as well as depression and quality of life.
Method: Participants with problematic alcohol use who, after an initial evaluation
consisting of five face-to-face sessions with a licensed psychologist where alcohol and
collateral problems are extensively assessed, are recommended treatment for problematic
alcohol use. Consenting participants will be randomized into one of two groups: 1. Internet
delivered relapse prevention with therapist support or 2. Face-to-face therapy. Outcomes on
alcohol use, depression and quality of life as well as information on user satisfaction will
be gathered post treatment. Follow up will be at 3, 6 and 12 months after completion.
Our hypothesis is that the internet-based program with therapist support and the
face-to-face therapy will be equally effective in reducing alcohol use (non-inferiority).
Status | Terminated |
Enrollment | 1 |
Est. completion date | March 2016 |
Est. primary completion date | March 2016 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: Problematic alcohol use and having been recommended psychotherapy by the assessing psychologist. Exclusion Criteria: Inadequate Swedish language skills No Internet access Reading and/or writing difficulties Major depression Current suicidal thoughts and/or plans Primary problematic drug use PTSD-related problems Psychosis Cognitive disability |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Sweden | Karolinska institutet, Department of Clinical Neuroscience | Stockholm |
Lead Sponsor | Collaborator |
---|---|
Karolinska Institutet |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Drug Use Identification Test (DUDIT) | Change in total DUDIT score, as a summarized measure of drug (including alcohol consumption and alcohol-related problems) | Post, 3, 6 and 12 months | No |
Other | Biological tests for alcohol markers | Biological marker outcomes post-treatment. B-PEth and CDT. | Post | No |
Primary | Alcohol Use Identification Test (AUDIT) | Change in total AUDIT score, as a summarized measure of alcohol use (including alcohol consumption and alcohol-related problems) | Post, 3, 6 and 12 months | No |
Secondary | Time Line Follow Back (TLFB) | Change in total TLFB score, as a summarized measure of alcohol consumption | Post, 3, 6 and 12 months | No |
Secondary | Montgomery Asberg Depression Rating Scale - Self report (MADRS-S) | Change in total MADRS-S score, as a summarized measure of depression | Post, 3, 6 and 12 months | No |
Secondary | World Health Quality of Life Scale (WHOQOL-BREF) | Change in total WHOQOL-BREF score, as a summarized measure of quality of life | Post, 3, 6 and 12 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03165942 -
Neuroendocrine Response to Oral Alcohol Administration
|
Phase 1 | |
Recruiting |
NCT05343039 -
Technology Enhanced Adolescent Mental Health (TEAM)
|
N/A | |
Active, not recruiting |
NCT04070521 -
EEG Monitoring in the Emergency Department
|
||
Completed |
NCT03169244 -
Buproprion for Binge Drinking
|
Phase 2 | |
Recruiting |
NCT05246202 -
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
|
N/A | |
Completed |
NCT05036499 -
PFI for Pain-Related Anxiety Among Hazardous Drinkers With Chronic Pain
|
N/A | |
Recruiting |
NCT04368416 -
Anxiety/Depression, Sleep and Alcohol in Elderly Anxiety/Depression, Sleep Disturbances and Alcohol Use Disorder in Elderly With Cognitive Complaints
|
||
Not yet recruiting |
NCT04557631 -
Evaluation of the Threshold for the Interpretation of the Results of a Method for the Blood Determination of Phosphatidyléthanol
|
||
Terminated |
NCT00890149 -
Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults
|
Phase 2 | |
Completed |
NCT02681406 -
Smartphone Based Continuing Care for Alcohol
|
N/A | |
Completed |
NCT02179749 -
Mifepristone Treatment of Alcohol Use Disorder
|
Phase 2 | |
Completed |
NCT02448134 -
A Community-Based Strategy for Preventing Underage Drinking
|
N/A | |
Withdrawn |
NCT01796158 -
Pilot Test of Computerized MET to Reduce Adolescent Alcohol Use
|
N/A | |
Withdrawn |
NCT01847300 -
cSBI-M for Young Military Personnel
|
N/A | |
Withdrawn |
NCT01511679 -
Brain-imaging and Adolescent Neuroscience Consortium
|
N/A | |
Terminated |
NCT01408641 -
Topiramate for Alcohol Use in Posttraumatic Stress Disorder
|
N/A | |
Completed |
NCT01553136 -
Varenicline Treatment of Alcohol Dependence in Smokers
|
Phase 2 | |
Withdrawn |
NCT01275391 -
cSBIRT to Reduce Teen Tobacco, Alcohol and Drug Use
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT01539525 -
Screening to Augment Referral to Treatment- Project START
|
Phase 2 | |
Completed |
NCT01207258 -
Brief Intervention for Problem Drinking and Partner Violence
|
Phase 2 |